SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 144 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $905,000 | -10.1% | 39,165 | +2.0% | 0.00% | 0.0% |
| Q2 2023 | $1,007,000 | +20.3% | 38,401 | +18.0% | 0.00% | 0.0% |
| Q1 2023 | $837,000 | -2.2% | 32,535 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $856,000 | +7681.8% | 32,928 | +24111.8% | 0.00% | – |
| Q3 2022 | $11,000 | +22.2% | 136 | -64.7% | 0.00% | – |
| Q2 2022 | $9,000 | -59.1% | 385 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | -8.3% | 385 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | 0.0% | 385 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | -25.0% | 385 | 0.0% | 0.00% | – |
| Q2 2021 | $32,000 | +14.3% | 385 | 0.0% | 0.00% | – |
| Q1 2021 | $28,000 | -22.2% | 385 | -23.5% | 0.00% | – |
| Q4 2020 | $36,000 | +50.0% | 503 | 0.0% | 0.00% | – |
| Q3 2020 | $24,000 | +14.3% | 503 | 0.0% | 0.00% | – |
| Q2 2020 | $21,000 | – | 503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71,239,818 | 7.97% |
| Finepoint Capital LP | 556,928 | $12,876,175 | 6.41% |
| M28 Capital Management LP | 197,700 | $4,570,824 | 5.24% |
| Boxer Capital, LLC | 3,421,541 | $79,106,028 | 4.21% |
| Deep Track Capital, LP | 3,546,435 | $81,993,577 | 3.16% |
| EcoR1 Capital, LLC | 3,460,208 | $80,000,009 | 2.70% |
| Orbimed Advisors | 3,968,588 | $91,753,755 | 1.95% |
| Artal Group S.A. | 1,816,620 | $42,000 | 1.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 319,911 | $7,396,342 | 1.35% |
| Perceptive Advisors | 1,520,416 | $35,152,017 | 1.17% |